Dr. Christopher D'Angelo
Claim this profileUniversity of Nebraska Medical Center
Studies Lymphoma
Studies Multiple Myeloma
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Christopher D'Angelo is currently running
Tirabrutinib
for Central Nervous System Lymphoma
This trial is testing tirabrutinib alone and with other cancer drugs in patients with PCNSL. It targets those who haven't responded to previous treatments or are newly diagnosed. Tirabrutinib works by blocking a protein that helps cancer cells grow. Tirabrutinib was approved for use in treating primary central nervous system lymphoma.
Recruiting1 award Phase 210 criteria
Prebiotics
for Multiple Myeloma
Higher gut microbiome diversity has been associated with improved survival following autologous stem cell transplantation in multiple myeloma and lymphoma. This study hypothesises that prebiotic supplementation with resistant starch (RS) will improve gut microbiome diversity at time of stem cell engraftment. To test this, participants will either have RS or a placebo (maltodextrin) mixed into a food item of their choice for approximately 10 days prior to stem cell infusion and continue to the first day of neutrophil engraftment. The study will look at the difference in gut microbiome diversity between the RS and placebo arm collected at the engraftment timepoint, dietary evaluation to assess the impact of subject diet on microbiome response to intervention and serum sample collection to assess differences to gut permeability during transplant.
Recruiting0 awards N/A6 criteria
More about Christopher D'Angelo
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Christopher D'Angelo has experience with
- Maltodextrin
- Resistant Starch
- Tirabrutinib
Breakdown of trials Christopher D'Angelo has run
Multiple Myeloma
Plasma Cell Neoplasm
Central Nervous System Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher D'Angelo specialize in?
Christopher D'Angelo focuses on Lymphoma and Multiple Myeloma. In particular, much of their work with Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Christopher D'Angelo currently recruiting for clinical trials?
Yes, Christopher D'Angelo is currently recruiting for 2 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Christopher D'Angelo has studied deeply?
Yes, Christopher D'Angelo has studied treatments such as Maltodextrin, Resistant Starch, Tirabrutinib.
What is the best way to schedule an appointment with Christopher D'Angelo?
Apply for one of the trials that Christopher D'Angelo is conducting.
What is the office address of Christopher D'Angelo?
The office of Christopher D'Angelo is located at: University of Nebraska Medical Center, Omaha, Nebraska 68198 United States. This is the address for their practice at the University of Nebraska Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.